@article{JTD24119,
author = {Mariam Alexander and Jose Galeas and Haiying Cheng},
title = {Tumor mutation burden in lung cancer: a new predictive biomarker for immunotherapy or too soon to tell?},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 33},
year = {2018},
keywords = {},
abstract = {Immunotherapy with immune-checkpoint inhibitors (ICIs) has shifted the therapeutic landscape in lung cancer. At the same time, the clinical benefits of ICIs in unselected patients remain modest.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/24119}
}